
Proceedings Paper
Development and characterization of silk fibroin coated quantum dotsFormat | Member Price | Non-Member Price |
---|---|---|
$17.00 | $21.00 |
Paper Abstract
Recent progress in the field of semiconductor nanocrystals or Quantum Dots (QDs) has seen them find wider
acceptance as a tool in biomedical research labs. As produced, high quality QDs, synthesized by high temperature
organometallic synthesis, are coated with a hydrophobic ligand. Therefore, they must be further processed to be
soluble in water and to be made biocompatible. To accomplish this, the QDs are generally coated with a synthetic
polymer (eg. block copolymers) or the hydrophobic surface ligands exchanged with hydrophilic material (eg. thiols).
Advances in this area have enabled the QDs to experience a smooth transition from being simple inorganic
fluorophores to being smart sensors, which can identify specific cell marker proteins and help in diagnosis of diseases
such as cancer.
In order to improve the biocompatibility and utility of the QDs, we report the development of a procedure to coat QDs
with silk fibroin, a fibrous crystalline protein extracted from Bombyx Mori silkworm. Following the coating process,
we characterize the size, quantum yield and two-photon absorption cross section of the silk coated QDs. Additionally,
the results of biocompatibility studies carried out to compare the properties of these QD-silks with conventional QDs
are presented. These natural polymer coatings on QDs could enhance the intracellular delivery and enable the use of
these nanocrystals as an imaging tool for studying subcellular machinery at the molecular level.
Paper Details
Date Published: 13 March 2008
PDF: 8 pages
Proc. SPIE 6866, Colloidal Quantum Dots for Biomedical Applications III, 686607 (13 March 2008); doi: 10.1117/12.764061
Published in SPIE Proceedings Vol. 6866:
Colloidal Quantum Dots for Biomedical Applications III
Marek Osinski; Thomas M. Jovin; Kenji Yamamoto, Editor(s)
PDF: 8 pages
Proc. SPIE 6866, Colloidal Quantum Dots for Biomedical Applications III, 686607 (13 March 2008); doi: 10.1117/12.764061
Show Author Affiliations
B. B. Nathwani, M.D. Anderson Cancer Ctr. (United States)
Texas A&M Univ. (United States)
C. Needham, Texas A&M Univ. (United States)
Texas A&M Univ. (United States)
C. Needham, Texas A&M Univ. (United States)
A. B. Mathur, M.D. Anderson Cancer Ctr. (United States)
K E. Meissner, Texas A&M Univ. (United States)
K E. Meissner, Texas A&M Univ. (United States)
Published in SPIE Proceedings Vol. 6866:
Colloidal Quantum Dots for Biomedical Applications III
Marek Osinski; Thomas M. Jovin; Kenji Yamamoto, Editor(s)
© SPIE. Terms of Use
